Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails

ClinicalTrials.gov ID: NCT01208168

Public ClinicalTrials.gov record NCT01208168. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 11:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Study of the Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenails for 52 Wks

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objectives of this study are to assess the safety of NAB001 for topical treatment of mild to moderate distal onychomycosis of the toenails over 52 weeks and to compare the efficacy of NAB001 to vehicle alone at the end of the study (Week 56) after treating for 52 weeks.

Study identification

NCT ID
NCT01208168
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Promius Pharma, LLC
Industry
Enrollment
468 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2010 (Type not available)
Primary completion
Jul 2012 (Actual)
Completion
Jul 2012 (Actual)
Last update posted
Jul 11, 2013

2010 – 2012

United States locations

U.S. sites
22
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
Not listed Phoenix Arkansas 85032 —
T. Joseph Raoof, MD, Inc. Encino California 91436 —
Skin Surgery Medical Group, Inc. San Diego California 92117 —
Longmont Medical Research Network Longmont Colorado 80501 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
Internaional Dermatology Research, Inc. Miami Florida 33144 —
MedaPhase, Inc. Newnan Georgia 30263 —
Clinical Research Atlanta Stockbridge Georgia 30281 —
Northwest Clinical Trials Boise Idaho 83704 —
Minnesota Clinical Study Center Fridley Minnesota 55432 —
Gerard Furst, DPM, PLLC East Setauket New York 11733 —
Dermatology Consulting Services High Point North Carolina 27262 —
Wake Research Associates Raleigh North Carolina 27612 —
Mazur Foot and Ankle Salisbury North Carolina 28144 —
Radiant Research Cincinnati Ohio 45249 —
Oregon Dermatology & Research Network Portland Oregon 97210 —
Temple University - School of Podiatric Medicine Philadelphia Pennsylvania 19107 —
Carolina Dermatology of Greenville, PA Greenville South Carolina 29681 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464 —
Tennessee Clinical Research Center Nashville Tennessee 37215 —
Ashton Podiatry Associates, PA Dallas Texas 75243 —
Progressive Clinical Research San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01208168, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 11, 2013 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01208168 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →